Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|73|1|230-238

ISSN： 0105-4538

Source： ALLERGY, Vol.73, Iss.1, 2018-01, pp. : 230-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Mastocytosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 14, Iss. 5, 1987-10 ,pp. : 483-490

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis

By  

International Archives of Allergy and Immunology, Vol. 169, Iss. 2, 2016-04 ,pp. : 125-129

Karger

Access to resources Recommend Favorite

Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 4, 2011-11 ,pp. : 399-405

Karger

Access to resources Recommend Favorite

Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-10 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

An Elderly Gentleman with Systemic Mastocytosis

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 35, Iss. 8, 1987-08 ,pp. : 821-822

John Wiley & Sons Inc

Access to resources Recommend Favorite